Campbell & CO Investment Adviser LLC Invests $788,000 in Pediatrix Medical Group, Inc. $MD

Campbell & CO Investment Adviser LLC acquired a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 54,911 shares of the company’s stock, valued at approximately $788,000. Campbell & CO Investment Adviser LLC owned about 0.06% of Pediatrix Medical Group as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the company. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Pediatrix Medical Group by 284.6% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 175,987 shares of the company’s stock valued at $2,525,000 after purchasing an additional 130,226 shares during the period. Hussman Strategic Advisors Inc. boosted its holdings in shares of Pediatrix Medical Group by 150.0% in the second quarter. Hussman Strategic Advisors Inc. now owns 210,000 shares of the company’s stock worth $3,014,000 after buying an additional 126,000 shares during the last quarter. Wakefield Asset Management LLLP bought a new stake in Pediatrix Medical Group during the second quarter valued at approximately $1,002,000. Atria Investments Inc grew its position in Pediatrix Medical Group by 9.4% during the second quarter. Atria Investments Inc now owns 16,435 shares of the company’s stock valued at $236,000 after buying an additional 1,411 shares during the period. Finally, Keybank National Association OH purchased a new stake in Pediatrix Medical Group during the second quarter valued at approximately $226,000. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Price Performance

NYSE:MD opened at $22.61 on Friday. The business’s 50-day simple moving average is $17.75 and its two-hundred day simple moving average is $15.40. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $22.98. The stock has a market cap of $1.94 billion, a PE ratio of 17.53 and a beta of 1.20. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.67 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.21. The firm had revenue of $492.88 million during the quarter, compared to analyst estimates of $476.45 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The business’s quarterly revenue was down 3.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.44 earnings per share. As a group, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

MD has been the topic of several analyst reports. Truist Financial lifted their price target on shares of Pediatrix Medical Group from $17.00 to $24.00 and gave the stock a “hold” rating in a research note on Monday. UBS Group raised their target price on Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a report on Wednesday, November 5th. Wall Street Zen raised Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 4th. Zacks Research cut Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 7th. Finally, Leerink Partners raised their price objective on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $19.80.

Insider Transactions at Pediatrix Medical Group

In other news, Director Laura A. Linynsky sold 10,000 shares of Pediatrix Medical Group stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $21.65, for a total transaction of $216,500.00. Following the sale, the director owned 32,232 shares in the company, valued at $697,822.80. This trade represents a 23.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.90% of the stock is currently owned by company insiders.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.